Arnicare Value Pack
Arnicare Value Pack is an FDA drug label for the active ingredient ARNICA MONTANA manufactured by Laboratoires Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231127.
- Generic name
- ARNICA MONTANA
- Manufacturer
- Laboratoires Boiron
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 0220-9042
- Application
- N/A
- Label effective
- 20231127
Active ingredients
Indications & Usage
Uses* temporarily relieves muscle pain and stiffness due to: minor injuries overexertion falls reduces symptoms of bruising such as: pain swelling discoloration
Dosage & Administration
Directions ARNICARE GEL: Apply a thin layer of Arnicare Gel to affected area as soon as possible after minor injury. Repeat 3 times a day or as needed. If heat or ice is applied, wait 5 minutes before applying Arnicare Gel. ARNICA 30C PELLETS: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Arnicare Gel: For external use only.
Adverse Reactions
Not available.